Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
N4 Pharma ( (GB:N4P) ) just unveiled an announcement.
N4 Pharma PLC has announced a change in its major holdings, with Mathenz Marc Kay crossing a voting rights threshold to hold 9.12% of the company’s voting rights, up from a previous 8.36%. This change reflects a significant shift in shareholder composition, potentially impacting the company’s governance and strategic decisions.
More about N4 Pharma
N4 Pharma PLC is a pharmaceutical company focused on developing novel delivery systems for vaccines and therapeutics. The company operates within the biotech industry and aims to enhance the effectiveness of existing drugs through its proprietary technologies.
YTD Price Performance: 4.76%
Average Trading Volume: 2,042,705
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £5.97M
For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.
